The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
TRANSENTERIX INC | COM NEW | 89366M201 | 179 | 510,142 | SH | OTR | 0 | 510,142 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 3,110 | 628,236 | SH | OTR | 0 | 628,236 | 0 | ||
CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 1,186 | 285,765 | SH | OTR | 0 | 285,765 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 13,155 | 1,719,576 | SH | OTR | 0 | 1,719,576 | 0 | ||
DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 18,525 | 449,951 | SH | OTR | 1,2 | 0 | 449,951 | 0 | |
X4 PHARMACEUTICALS INC | COM | 98420X103 | 3,115 | 311,490 | SH | OTR | 1,2 | 0 | 311,490 | 0 | |
AVROBIO INC | COM | 05455M100 | 19,234 | 1,236,123 | SH | OTR | 1,2 | 0 | 1,236,123 | 0 | |
SUTRO BIOPHARMA INC | COM | 869367102 | 18,610 | 1,824,542 | SH | OTR | 0 | 1,824,542 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 26,143 | 1,915,274 | SH | OTR | 1,2 | 0 | 1,915,274 | 0 | |
MISONIX, INC. | COM | 604871103 | 15,976 | 1,695,969 | SH | OTR | 1,2 | 0 | 1,695,969 | 0 |